Maneuvering Clinical Pathways for Ulcerative Colitis

Recent years have brought about several advances in the treatment of patients with ulcerative colitis (UC). Here, we discuss salient recommendations of recent treatment guidelines; review the efficacy, safety, and real-world data of vedolizumab and tofacitinib; appraise their place vis-a-vis established agents; and consider the newly proposed approaches of risk-stratified and treat-to-target therapy. Once daily oral mesalamine dosing is...